OCUL
Ocular Therapeutix, Inc.NASDAQHealthcare$8.49+1.92%ClosedMarket Cap: $1.85B
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
20
Sales
11
Buy/Sell Ratio
1.82
Total Bought
$1.00
Total Sold
$11.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Wed Feb 25 | Dugel Pravin | director, officer: See Remarks | Sell | 20,056 | $8.28 | 3,013,022 |
| Wed Feb 25 | Kaiser Peter | officer: Chief Development Officer | Sell | 2,810 | $8.28 | 269,108 |
| Wed Feb 25 | Heier Jeffrey S. | officer: Chief Scientific Officer | Sell | 3,057 | $8.28 | 323,368 |
| Wed Feb 25 | Nayak Sanjay | officer: Chief Strategy Officer | Sell | 1,759 | $8.28 | 330,653 |
| Tue Feb 24 | Waheed Nadia | officer: Chief Medical Officer | Sell | 3,510 | $7.74 | 314,907 |
| Tue Feb 24 | LINDSTROM RICHARD L MD | director | Buy | 60,229 | $7.66 | 246,933 |
| Tue Feb 17 | Notman Donald | officer: Chief Operating Officer | Sell | 11,446 | $9.04 | 366,356 |
| Tue Feb 17 | Nayak Sanjay | officer: Chief Strategy Officer | Sell | 10,348 | $9.04 | 332,412 |
| Tue Feb 17 | Dugel Pravin | director, officer: See Remarks | Sell | 124,882 | $9.04 | 3,033,078 |
| Tue Feb 17 | Waheed Nadia | officer: Chief Medical Officer | Sell | 7,863 | $9.04 | 318,417 |